You are viewing: Asia Pacific Nuclear Medicine Equipment Market analysis

The Asia Pacific Nuclear Medicine Equipment Market was valued at $1501.2 Million in 2025 and projected to reach to $1938.2 Million by 2030, representing a compound annual growth rate of 5.2%. The Asia Pacific nuclear medicine equipment market is poised for sustained expansion through 2030, driven by increasing healthcare expenditure, aging populations, and growing awareness of diagnostic imaging benefits.

Asia Pacific Nuclear Medicine Equipment Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific Nuclear Medicine Equipment Market Trends and Insights

  • Asia Pacific's market expansion is driven by increasing healthcare infrastructure investments, rising prevalence of chronic diseases, and growing adoption of diagnostic imaging technologies across the region.
  • The 5.2% compound annual growth rate reflects Asia Pacific's accelerating demand for advanced nuclear medicine solutions, supported by improving reimbursement policies and expanding patient populations in emerging economies. Asia Pacific's nuclear medicine equipment sector benefits from technological advancements in SPECT and PET imaging systems, coupled with rising awareness of early disease detection.
  • The region's market growth from 2025 to 2030 is underpinned by government initiatives to modernize healthcare facilities and increasing investments by private healthcare providers.
  • Asia Pacific's competitive landscape features both established global manufacturers and emerging regional players, positioning the region as a critical growth hub for nuclear medicine equipment innovation and deployment..

Key Market Statistics

  • CAGR (2025-2030) 5.2% CAGR
  • Market Size, 2025 ~USD 1501.2 Million
  • Forecast, 2030 ~USD 1938.2 Million
  • Geography Asia Pacific

Asia Pacific Nuclear Medicine Equipment Market Overview

Market Valuation & Growth :

Asia Pacific nuclear medicine equipment market valued at USD 1,501.2 million in 2025, expanding at a robust 5.2% CAGR through 2030, outpacing the global growth rate of 4.62%.

Healthcare Infrastructure Expansion :

Rapid investments in healthcare infrastructure across Asia Pacific nations are driving adoption of advanced nuclear medicine diagnostic equipment, particularly in emerging economies.

Chronic Disease Prevalence :

Rising incidence of cancer, cardiovascular diseases, and neurological disorders across Asia Pacific is accelerating demand for nuclear medicine imaging and diagnostic solutions.

Regional Market Leadership :

Japan leads the region with USD 668.9 million market size, followed by China at USD 565.9 million, reflecting strong healthcare spending and technological adoption in developed Asian markets.

Asia Pacific Nuclear Medicine Equipment Market Dynamics

  • Countries like Japan, China, and India are investing heavily in modernizing their healthcare facilities and acquiring advanced nuclear medicine technologies.
  • The region's 5.2% CAGR reflects strong demand for PET/CT scanners, SPECT systems, and related diagnostic equipment. Key growth catalysts include government healthcare initiatives, rising middle-class populations seeking quality medical care, and technological advancements making equipment more accessible and affordable.
  • Emerging markets within Asia Pacific present significant opportunities for market players, while established markets continue to upgrade aging infrastructure with next-generation nuclear medicine solutions..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Asia Pacific nuclear medicine equipment market valued at USD 1,501.2 million in 2025, expanding to USD 1,938.2 million by 2030 at 5.2% CAGR
    • Asia Pacific's growth driven by healthcare infrastructure modernization, rising chronic disease prevalence, and increased diagnostic imaging adoption
    • Asia Pacific benefits from technological advancements in SPECT and PET systems with improving reimbursement policies supporting market expansion
    • Asia Pacific's competitive landscape includes global manufacturers and regional players, establishing the region as a critical growth hub for nuclear medicine innovation

    Nuclear Medicine Equipment Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIAGNOSTIC IMAGING CENTERS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 4.62% from 2025 to 2030
    Largest Segment IMAGING MODALITIES (System Type)
    Market Size Base Year (Billions) ~USD 6.63 (2025)
    Revenue Forecast (Billions) ~USD 8.31 (2030)
    Segments Covered System Type, Type, Therapeutic Area, Dimension, End User, Type 2023–2030

    Asia Pacific Nuclear Medicine Equipment Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By System Type

    • Imaging Modalities
    • Non- Imaging Modalities
    • Non-Imaging Modalities

    By Type

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gamma/Scintillation Cameras
    • Gm Counters
    • Hybrid Pet
    • Hybrid Spect
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect
    • Standalone Pet
    • Standalone Spect

    By Therapeutic Area

    • Cardiology
    • Neurology
    • Oncology
    • Orthopedics
    • Other Therapeutic Areas
    • Thyroid

    By Dimension

    • 2D
    • 3D

    By End User

    • Cancer Treatment Centers
    • Diagnostic Imaging Centers
    • Hospitals
    • Other End Users

    By Type 2023–2030

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gm Counters
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect

    Target Audience

    • Medical Device Manufacturers : Manufacturers of nuclear medicine equipment need Asia Pacific market data to develop region-specific product strategies, identify distribution partnerships, and allocate R&D resources for high-growth markets.
    • Healthcare Investors & PE Firms : Investment professionals require detailed market sizing and growth forecasts for Asia Pacific to evaluate acquisition targets, portfolio companies, and investment opportunities in the nuclear medicine sector.
    • Hospital & Diagnostic Center Operators : Healthcare facility operators need market intelligence on equipment trends, pricing, and technology adoption patterns in Asia Pacific to make informed capital equipment purchasing decisions.
    • Market Consultants & Analysts : Consulting firms and research analysts require comprehensive Asia Pacific market data to support client advisory services, competitive analysis, and strategic planning engagements.
    • Government & Healthcare Policy Makers : Policy makers and healthcare administrators need market insights to inform healthcare infrastructure planning, technology adoption initiatives, and regulatory frameworks across Asia Pacific nations.

    Key Companies in the Asia Pacific Nuclear Medicine Equipment Market

    CompanyHQOwnershipStrongest segments
    PHILIPSNetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma),Software (Image Management, PACS, Treatment, Analytics, Workflow),Detectors & Counters (GM Counter, Dose Calibrator and Related),
    DIGIRAD CORPORATIONUnited StatesPrivate CompanyImaging – SPECT / Gamma cameras,Imaging – PET,Radiation detection (GM counters, dose calibrators),
    TOSHIBA CORPORATIONJapanPrivate CompanyImaging Equipment (PET, SPECT, Gamma),Radiation Measurement (GM Counter, Dose Calibrator),Software (Image Management, PACS, Treatment, Analytic, Workflow),
    SIEMENS AGGermanyPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Treatment, Analytics, Workflow),Therapy-adjacent Solutions (Onco, Cardio, Neuro, Ortho Planning/Support),
    GE HEALTHCAREUnited StatesPublic CompanyImaging – PET,Imaging – SPECT,Imaging – Gamma cameras,
    SIEMENS HEALTHINEERS AGGermany
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Analytics, Workflow, Treatment Planning Interfaces),Therapy-related Applications (Oncology, Cardiology, Neurology, Orthopedic Planning),
    MIRION TECHNOLOGIES, INC.United StatesPublic CompanyImaging-related equipment (PET/SPECT/Gamma-adjacent QA, detectors, cameras),Radiation measurement & counters (GM counters, dose calibrators, health-physics),Software (image/spectroscopy analysis, QA, workflow, treatment support),
    DOSISOFT SAFrancePrivate CompanyImaging-related software (PET/SPECT/Gamma image management & PACS integration),Treatment planning & dosimetry software (Onco/Cardio/Neuro/Ortho),Analytics & workflow orchestration,
    SEGAMI CORPORATIONJapanPrivate CompanyImaging Equipment (PET/SPECT/Gamma),GM Counters & Dose Calibrators,Nuclear Medicine Software (Image Management, PACS, Treatment, Analytic, Workflow),
    LABLOGIC SYSTEMS LTD.United KingdomPrivate CompanyImaging-adjacent QC hardware (gamma counters, dose calibrator-related QC, radiochromatography hardware),CDS / Image & data management software for radiopharmaceutical workflows,LIMS / workflow and analytic software for nuclear medicine and radiochemistry labs,

    PHILIPS

    Philips is a Dutch multinational public company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors.

    DIGIRAD CORPORATION

    Digirad Corporation is a United States-based private company founded in 1985 with 194 employees.

    TOSHIBA CORPORATION

    Toshiba Corporation is a Japanese private company founded in 1875 with 106,648 employees, operating across multiple industrial and technology sectors.

    SIEMENS AG

    Siemens AG is a German public company founded in 1847 with 310,312 employees, operating across industrial, infrastructure, and healthcare sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German healthcare company within the Siemens group.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating across healthcare, consumer lifestyle, and lighting sectors.

    MIRION TECHNOLOGIES, INC.

    Mirion Technologies, Inc. is a United States-based public company founded in 2005 with 3,281 employees.

    DOSISOFT SA

    Dosisoft SA is a French private company founded in 2002.

    SEGAMI CORPORATION

    Segami Corporation is a Japanese private company with 1,501 employees.

    LABLOGIC SYSTEMS LTD.

    Lablogic Systems Ltd. is a United Kingdom-based private company founded in 1980.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 3555.6 Million · 4.4% wtd CAGR ·
    Europe
    ~USD 2157.1 Million · 4.7% wtd CAGR ·
    Latin America
    ~USD 287.8 Million · 3.5% wtd CAGR ·
    Middle East & Africa
    ~USD 372.1 Million · 3.8% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    JapanUSD 668.9 Million
    ChinaUSD 565.9 Million
    IndiaUSD 332.7 Million
    South KoreaUSD 116.6 Million
    AustraliaUSD 113.1 Million
    Rest Of Asia PacificUSD 141.1 Million

    Country market size visualization

    Japan
    USD 668.9 Million
    China
    USD 565.9 Million
    India
    USD 332.7 Million
    South Korea
    USD 116.6 Million
    Australia
    USD 113.1 Million
    Rest Of Asia Pacific
    USD 141.1 Million

    Reasons to Buy this Report

    • Regional Market Insights : Gain detailed understanding of Asia Pacific's nuclear medicine equipment market dynamics, including country-specific trends, competitive landscape, and growth opportunities across the region's diverse healthcare markets.
    • Strategic Expansion Planning : Identify high-growth markets within Asia Pacific with specific market size data for Japan, China, India, South Korea, and Australia to prioritize market entry and expansion strategies.
    • Investment Decision Support : Access comprehensive market forecasts through 2030 with 5.2% CAGR projections to support capital allocation decisions and long-term business planning in the Asia Pacific region.
    • Competitive Benchmarking : Compare Asia Pacific market performance against global benchmarks (4.62% global CAGR) to assess regional competitiveness and identify market share opportunities.
    • Healthcare Trend Analysis : Understand key drivers including healthcare infrastructure investments, chronic disease prevalence, and diagnostic imaging adoption patterns specific to Asia Pacific markets.

    Frequently asked questions

    What is the current market size of nuclear medicine equipment in Asia Pacific?

    The Asia Pacific nuclear medicine equipment market is valued at USD 1,501.2 million in 2025.

    What is the projected market size for Asia Pacific nuclear medicine equipment by 2030?

    Asia Pacific's nuclear medicine equipment market is projected to reach USD 1,938.2 million by 2030.

    What is the growth rate for nuclear medicine equipment in Asia Pacific?

    Asia Pacific's nuclear medicine equipment market is expected to grow at a compound annual growth rate of 5.2% from 2025 to 2030.

    What factors are driving growth in Asia Pacific's nuclear medicine equipment market?

    Asia Pacific's market growth is driven by healthcare infrastructure investments, rising chronic disease prevalence, technological advancements in imaging systems, and improving reimbursement policies.

    Which imaging technologies are most prominent in Asia Pacific's nuclear medicine market?

    SPECT and PET imaging systems are the most prominent technologies in Asia Pacific's nuclear medicine equipment market, supported by increasing adoption for early disease detection.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine equipment market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine equipment market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

    Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

    After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine equipment offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

    In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

    Breakdown of Primary Interviews

    Nuclear Medicine Equipment Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, therapeutic area, dimension, end user, and region).

    Nuclear Medicine Equipment Market

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine equipment market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine equipment market.

    Market Definition

    Nuclear medicine equipment refers to specialized medical devices used to perform diagnostic and therapeutic procedures involving radioactive substances. These include imaging systems such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanners, as well as gamma cameras and hybrid imaging systems. The equipment enables the detection, imaging, and tracking of radiopharmaceuticals within the body, playing a crucial role in disease diagnosis, monitoring, and targeted radionuclide therapy.

    Stakeholders

    • Nuclear Medicine Equipment Vendors & Imaging Device Manufacturers
    • Healthcare Providers (Hospitals, Outpatient Settings, Diagnostics & Imaging Centers, Radiopharmacies, Other Healthcare Providers)
    • Clinical Research Organizations (CROs)
    • Research & Development (R&D) Companies
    • Business Research & Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Centers/Universities/Hospitals/Research Institutes
    • Regulatory Bodies (FDA, EMA, IAEA)
    • AI & Algorithm Developers
    • Venture Capitalists
    • Advocacy Groups
    • Investors & Financial Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Contract Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the nuclear medicine equipment market by product type, therapeutic area, dimension, end user, and region
    • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nuclear medicine equipment market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the nuclear medicine equipment market in five main regions (and their respective countries): North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
    • To provide key industry insights, such as supply chain, regulatory, patent, and recession impact analysis
    • To profile the key players in the market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches & upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, funding, and expansions of the leading players in the market
    • To benchmark players within the market using the company evaluation matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Nuclear Medicine Equipment Market Report

    Full forecast, segment splits, and company analysis for all Nuclear Medicine Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status